Gustavo Alza, MD
Internal Medicine Physician in Los Angeles, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 172,737 in Internal Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Gustavo Alza, MD reported a CMS MIPS final score of 97.7/100 - above the 83.5 national average - and filed 5,429 Medicare Part D claims in 2023.
- 97.7/100
- MIPS score · +14 vs avg
- 5K
- Part D claims, 2023
- 85%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1942498464 · Internal Medicine Physician
NPI-10 · ENUM-MID · TAX-MEGA · MIPS-ELITE · RX-MID · BOOK-MID · PHOTO-FINISH
- NPI-10 1942498464
- ENUM-MID 2007
- TAX-MEGA 173K Internal Medicine
- MIPS-ELITE 97.7/100
- RX-MID 5,429
- BOOK-MID 20,046 in California
- PHOTO-FINISH Olusegun Oseni · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Alza · this prov…
Alza · this provider
97.7 MIPS pts
- Orhan Sancaktar …
Orhan Sancaktar
97.7 MIPS pts
- Olusegun Oseni ·…
Olusegun Oseni
97.7 MIPS pts
- Svien Senne · hi…
Svien Senne
97.8 MIPS pts
- Gregory Erickson…
Gregory Erickson
97.8 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Gustavo Alza, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
98 ≥ 84th percentile 84% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Gustavo Alza, MD sits
This provider among internal medicine physician peers
Across the 34,612 internal medicine physician providers who report both Medicare Part D prescribing and a MIPS quality score, Gustavo Alza, MD writes more Part D claims than 83% of them and scores higher on MIPS quality than 88% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one internal medicine physician peer from a representative sample of 60; the gold marker is Gustavo Alza, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Gustavo Alza, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Gustavo Alza, MD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Internal Medicine Physician compares to other specialties among California providers
Internal Medicine Physician ranks #10 among California's specialties (2.1% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Internal Medicine Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Gustavo Alza, MD's 2023 MIPS final score plotted against the Internal Medicine Physician national average
- MIPS Final Score
- 97.7/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Internal Medicine Physician US NPIs
97.7/100 MIPS final score - 14.2 pts above the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Internal Medicine Physician. Quality dim: 96.4. Cost dim: 69.3.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1942498464 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 10/10/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Gustavo Alza, MD's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1942498464 is the unique 10-digit identifier CMS uses to link Alza across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Gustavo Alza, MD. Source: openpaymentsdata.cms.gov.
Total received
$999
Largest payer
Janssen Pharmaceuticals, Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Gustavo Alza, MD. To verify Gustavo Alza, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
14% brand-name claims vs 85% generic, on 5,429 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 8,634
- Total Day Supply
- 252,712
- Brand vs Generic
- 14% brand / 85% generic
- Brand Drug Cost
- $506K
- Generic Drug Cost
- $122K
- Opioid Claims
- 189 (3.5% rate)
- Antibiotic Claims
- 94
Patient Demographics
- Average Patient Age
- 79.6 years
- Avg HCC Risk Score
- 1.83
- Gender Split
- 57% female / 43% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Gustavo Alza, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Quetiapine Fumarate
Quetiapine Fumarate
260 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
245 claims
- Trazodone Hcl
Trazodone Hcl
220 claims
- Pioglitazone Hcl
Pioglitazone Hcl
199 claims
- Gabapentin
Gabapentin
186 claims
- Levothyroxine Sodium
Levothyroxine Sodium
174 claims
- Metformin Hcl
Metformin Hcl
160 claims
- Diclofenac Sodium
Diclofenac Sodium
158 claims
| Drug | Claims |
|---|---|
| Quetiapine Fumarate | 260 |
| Rosuvastatin Calcium | 245 |
| Trazodone Hcl | 220 |
| Pioglitazone Hcl | 199 |
| Gabapentin | 186 |
| Levothyroxine Sodium | 174 |
| Metformin Hcl | 160 |
| Diclofenac Sodium | 158 |
| Losartan Potassium | 136 |
| Ezetimibe | 124 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How Gustavo Alza, MD fits within the Internal Medicine Physician landscape nationally.
Gustavo Alza, MD's 5,429 claims are above the specialty average of 2,716.
Nationwide Internal Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Alza, both outside California so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (97.7 here).
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Internal Medicine Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Alza.
One of 20,046 Internal Medicine Physician providers enrolled in California, 5 are shown here.
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Gustavo Alza, MD's specialty? ▼
How much does Gustavo Alza, MD prescribe under Medicare Part D? ▼
What is Gustavo Alza, MD's Medicare quality score? ▼
Where is Gustavo Alza, MD located? ▼
What is Gustavo Alza, MD's NPI number? ▼
Does Gustavo Alza, MD prescribe more brand-name or generic drugs? ▼
Does Gustavo Alza, MD prescribe opioids? ▼
How many Internal Medicine Physician providers are there in the US? ▼
What drugs does Gustavo Alza, MD prescribe most often? ▼
Does Gustavo Alza, MD accept Medicare? ▼
How can I verify Gustavo Alza, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.